Modabpil, Abdorahma .
HRN: 23-90-28 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/16/2023
CO-AMOXICLAV 625MG (TAB)
10/16/2023
10/23/2023
ORAL
625mg
TID
Cap LR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes